Cromwell Holdings LLC Has $226,000 Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Cromwell Holdings LLC increased its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 17.3% during the third quarter, Holdings Channel.com reports. The firm owned 556 shares of the company’s stock after buying an additional 82 shares during the quarter. Cromwell Holdings LLC’s holdings in HCA Healthcare were worth $226,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of HCA. Tenon Financial LLC purchased a new stake in shares of HCA Healthcare in the third quarter valued at about $369,000. BayBridge Capital Group LLC raised its stake in shares of HCA Healthcare by 1.0% during the 3rd quarter. BayBridge Capital Group LLC now owns 3,485 shares of the company’s stock valued at $1,416,000 after purchasing an additional 35 shares during the period. Ballentine Partners LLC boosted its stake in HCA Healthcare by 2.7% in the 3rd quarter. Ballentine Partners LLC now owns 4,113 shares of the company’s stock worth $1,672,000 after purchasing an additional 107 shares during the period. Dakota Wealth Management purchased a new stake in shares of HCA Healthcare in the third quarter worth about $251,000. Finally, Jackson Wealth Management LLC bought a new stake in HCA Healthcare during the 3rd quarter worth approximately $282,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 15,345 shares of company stock worth $5,747,945. 1.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on HCA shares. Leerink Partners upped their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. UBS Group upped their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Barclays raised their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. Royal Bank of Canada raised their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 1st. Five equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and four have given a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $377.17.

Check Out Our Latest Stock Analysis on HCA

HCA Healthcare Price Performance

HCA opened at $363.75 on Friday. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The stock’s 50 day moving average price is $395.26 and its 200-day moving average price is $352.63. The stock has a market capitalization of $93.87 billion, a PE ratio of 17.08, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. HCA Healthcare, Inc. has a 52-week low of $220.55 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the business posted $4.29 EPS. On average, equities research analysts predict that HCA Healthcare, Inc. will post 22.48 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.73%. HCA Healthcare’s payout ratio is 12.39%.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.